Gilliam Joseph E sold 3,700 shares of GLAUKOS Corp at $244.49 for −$905k on Nov 12, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
PRESIDENT & COO
PRESIDENT & COO
Filed Nov 16, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$904,613Shares × reported price
Shares traded
3,700Common Stock
Price per share
$244.49Reported price. Read footnotes for ranges.
% of reported position traded
3.24%This security and ownership context
Holdings after
110,417Direct
Trade date
Nov 12, 2026Sell
Filed
Nov 16, 2026, 9:00 PM ET5-day reporting delay
Accession
0001193125-26-464222Code S · Transaction 402371
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 114,117 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 12, 2026Option exercise2,475$69.30$171,517.50Trade 402365
Nov 12, 2026Option exercise7,500$48.46$363,450Trade 402366
Nov 12, 2026Option exercise11,250$55.18$620,775Trade 402367
Nov 12, 2026Option exercise16,192$55.18$893,474.56Trade 402368
Nov 12, 2026Option exercise7,500$48.46$363,450Trade 402369
Nov 12, 2026Sell2,402$243.41−$584,670.82Trade 402370
Nov 12, 2026Sell8,015$245.77−$1,969,846.55Trade 402372
Nov 12, 2026Sell18,440$246.49−$4,545,275.60Trade 402373
Nov 12, 2026Sell12,060$247.50−$2,984,850Trade 402374
Nov 12, 2026Sell300$248.42−$74,526Trade 402375
Nov 12, 2026Option exercise2,475$0.00$0Trade 402376
Nov 12, 2026Option exercise7,500$0.00$0Trade 402377
Nov 12, 2026Option exercise11,250$0.00$0Trade 402379
Nov 12, 2026Option exercise16,192$0.00$0Trade 402380
15 transaction rows in this filing. Joint filers share the same rows.

GKOS price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
GKOS · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 24, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −32%1w ago −10%1d ago +0.9%
Returns since7d30d90d180d1y

Footnotes in full

F1: Includes 40,039 restricted stock units that have not yet vested or been delivered to the Reporting Person. F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 13, 2026. F3: This transaction was executed in multiple trades at prices ranging from $242.96 to $243.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. F4: This transaction was executed in multiple trades at prices ranging from $244.00 to $245.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. F5: This transaction was executed in multiple trades at prices ranging from $245.06 to $246.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. F6: This transaction was executed in multiple trades at prices ranging from $246.07 to $247.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. F7: This transaction was executed in multiple trades at prices ranging from $247.08 to $248.08. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. F8: This transaction was executed in multiple trades at prices ranging from $248.34 to $248.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. F9: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 13, 2026. F10: These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years. F11: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 22, 2023, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. F12: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer to the Reporting Person on March 24, 2022 in connection with his promotion to President and Chief Operating Officer, the vesting of which was subject to the Issuer's achievement of certain multi-year performance goals. F13: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period.